Sharifi-Sistani et al. [30] found MDM2 expression in 31 of 39 (79.48%) ameloblastomas, Krishna et al. [31] in 33 of 36 (91.6%) ameloblastomas, and Singh et al. [32] in 18 of 20 (90%) of conventional solid/multicystic ameloblastomas and 12 of 20 (60%) unicystic ameloblastomas. The gene discussed is MDM2; the disease is ameloblastoma.